Recent developments in the pharmacotherapy of substance abuse

Journal of Consulting and Clinical Psychology

Volumn 64, Issue 4, 1996, Pages 677-686

  O'Brien, Charles P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ALPHACETYLMETHADOL; BUPRENORPHINE; CANNABINOID; CANNABIS; COCAINE; LYSERGIDE; MESCALINE; METHADONE; NALOXONE; NALTREXONE; NICOTINE; OPIATE; OPIATE ANTAGONIST; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ALCOHOLISM; BEHAVIOR THERAPY; CANNABIS ADDICTION; CIGARETTE SMOKING; CLINICAL TRIAL; COMPULSION; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; HEROIN DEPENDENCE; HUMAN; LONG TERM CARE; MORPHINE ADDICTION; OPIATE ADDICTION; PSYCHOTHERAPY; REVIEW; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0029833028     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.64.4.677     Document Type: Review

References (57)

1. Alterman, A. I., Droba, M., Antelo, R. E., Cornish, J. W., Sweeney, K. K., Parikh, G., & O'Brien, C. P. (1992). Amantadine may facilitate detoxification of cocaine addicts. Drug and Alcohol Dependence, 31, 19-29.
2. Alterman, A. I., O'Brien, C. P., McLellan, A. T., August, D. S., Snider, E. C., Droba, M., Cornish, J. W., Hall, C. P., Raphaelson, A. H., & Schrade, F. X. (1994). Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. Journal of Nervous and Mental Disease, 182, 157-163.
3. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5. Annis, M. (1986). Is inpatient rehabilitation of the alcoholic cost effective? Con position. Advances in Alcoholism and Substance Abuse, 5(1-2), 175-90.
6. Ball, J. C., & Ross A. (1991). The effectiveness of methadone maintenance treatment. New York: Springer-Verlag.
7. Batki, S. L., Manfredi, L., Jacob, P. III, & Jones, R. T. (1993). Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine/benzoylecgonine concentrations. Journal of Clinical Psychopharmacology, 13, 243-250.
8. Brahen, L. S., Henderson, R. K., Copone, T., et al. (1984). Naltrexone treatment in a jail work-release program. Journal of Clinical Psychiatry, 45, 49.
9. Childress, A. R., Mozley, D., Fitzgerald, J., Reivich, M., Jaggi, J., & O'Brien, C. P. (1995). Limbic activation daring cue-induced cocaine craving. Neuroscience Abstracts, 21, 1956.
10. Cornish, J. W., Maany, I., Fudala, P. J., Neal, S., Poole, S. A., Volpicelli, P., & O'Brien, C. P. (1995). Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence, 38, 221-227.
11. Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988). Determination and characterization of a cannabenoid receptor in rat brain. Molecular Pharmacology, 34, 605-613.
12. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Mandelbaum, A., Etinger, A., & Mschoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
13. Droungas, A., Ehrman, R. N., Childress, A. R., & O'Brien, C. P. (1995). Effect of smoking cues and cigarette availability on craving and smoking behavior. Addictive Behaviors, 20, 657-673.
14. Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., Inciardi, J. A., Bowser B. P., Schilling, R. F., Holmberg, S. D., & Multicenter Crack Cocaine and HIV Infection Study Team. (1994). Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331, 1422-1427.
15. Everingham, S., & Rydell, C. (1994). Controlling cocaine. Santa Monica, CA: RAND.
16. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. Journal of the American Medical Association, 271, 1940-1946.
17. Gawin, F. H., Kleber, H. D., Byck, R., Rounsaville, B. J., Kosten, T. R., Jatlow, P. I., & Morgan, C. (1989). Desipramine facilitation of initial cocaine abuse. Archives of General Psychiatry, 46, 117-121.
18. Gerstein, D. R., Johnson, R. A., Harwood, H. J., Fountain, D., Suter, N. & Malloy, K. (1994). Evaluating recovery services: The California Drug and Alcohol Assessment (CALDATA). Sacramento: California Department of Alcohol and Drug Programs.
19. Gianoulakis, C. (1994). Genetics of alcoholism: Role of the endogenous opioid system. Journal of Metabolism and Brain Disorders, 9, 105-131.
20. Herkenham, M. A. (1993). Localization of cannabinoid receptors in brain: Relationship to motor and reward systems. In S. G. Korenman & J. D. Barchas (Eds.), Biological basis of substance abuse (Vol. 13, pp. 187-200). New York: Oxford University Press.
21. Higgins, S. T., Budney, A. J., Bickel, W. K., Badger G. J., Foerg, F. E., & Ogden, D. (1995). Outpatient behavioral treatment for cocaine dependence: One-year outcome. Experimental and Clinical Psychopharmacology, 3, 205-212.
22. Higgins, S. T., Budney, A. J., Bickel, W. K., Foerg, F. E., Ogden, D., & Badger, G. J. (1994). Outpatient behavioral treatment for cocaine dependence: One-year outcome. Paper presented at College on Problems of Drug Dependence Symposium.
23. Hobbard, R. L. Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press.
24. Institute of Medicine Report. (1990). The effectiveness of treatment. In D. R. Gerstein & H. J. Harwood (Eds.), Treating drug problems (pp. 132-199). Washington, DC: National Academy Press.
25. Jones, R. T., Benowitz, N. L., Herning, R. I. (1981). Clinical review of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21, (Suppl.), 143S-152S.
26. Kreek, M. J. (1992). Rationale for maintenance pharmacotherapy of opiate dependence. In C. P. O'Brien & J. H. Jaffe (Eds.), Addictive states (pp. 205-230). New York: Raven Press.
27. Martin, W. R., & Jasinski, D. (1969). Psychological Parameters of morphine in man tolerance, early abstinence, protracted abstinence. Journal of Psychiatry Research, 7, 9-16.
28. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, W. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
29. McLellan, A. T., Arndt, I. O., Metzger, D., Woody, G., & O'Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatmem. Journal of the American Medical Association, 269, 1959-1993.
30. Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989). Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science, 245, 859-862.
31. Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., & Abrutyn, E. (1993). Human immunodeficiency virus seroconversion along in- and out-of-treatment drug users: An 18-month prospective follow-up. Journal of AIDS, 6, 1049-1056.
32. Mintz, J., O'Brien, C. P., & Goldschmidt, J. (1974). Sexual problems of heroin addicts when drug free, on heroin, and on methadone. Archives of General Psychiatry, 31, 700-703.
33. Myer, E. C., Morris, D. L., Brase, D. A., Dewey, W. L., & Zimmerman, A. W. (1990). Naltrexone therapy of apnea in children with elevated cerebrospinal fluid 6-endorphin. Annals cf Neurology, 27, 75-80.
34. Nestler, E. J., Hope, B. T., & Widnell, K. L. (1993). Drug addiction: A model for the molecular basis of neurual plasticity. Neuron. 11, 995-1006.
35. Novick, D. M., Pascarelli, E. F., & Joseph, H. (1988). Methadone maintenance patients in general medical practice: A preliminary report. Journal of the American Medical Association, 259, 3299-3302.
36. O'Brien, C. P. (1992). Opioid addiction. In A. Herz (Ed.), Handbook of Experimental Pharmacology (Vol. 104/11 Opioids II, pp. 803-823). Berlin: Springer-Verlag.
37. O'Brien, C. P., Childless, A. R., McLellan, T., & Ehrman, R. (1990). Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors, 15, 355-365.
38. O'Brien, C. P., &. McLellan, A. T. (1996). Myths about the treatment of addiction. Lancet, 347, 237-240.
39. O'Malley, S. S., Jaffe, J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry, 49, 881-887.
40. Peroutka, S. J. (1994). 5-Hydroxytryptamine receptor interactions of d-lysergic acid diethylamide. In A. Pletscher & D. Ladewig (Eds.), 50 years of LSD (pp. 19-26). New York: Parthenon.
41. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994). Pharmacological characterization of the cloned α-, δ-, and μ-opioid receptors. Molecular Pharmacology 45, 330-334.
42. Ricuarte, G., Byran, G., Strauss, L., Seiden, L., & Schuster, C. R. (1985). Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science, 229, 986-988.
43. Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. H. (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science, 237, 1219-1223.
44. Rose, J. E., Behm, F. M., Westman, E. C., Levin, E. D., Stein, R. M., Ripka, G. V. (1994). Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clinical Pharmacology and Therapeutics, 56, 86-99.
45. Russell, M. A. H. (1987). Nicotine intake and its regulation by smokers. In W. D. Martin, G. R. Van Loon, E. T. Iwamoto, & L. Davis (Eds.), Tobacco smoking and nicotine (p. 25). New York: Plenum Press.
46. Satel, S. L., Price, L. H., Palumbo, J., McDougle, C. J., Krystal, J. H., Gawin, F. H., Charney, D. S., Heninger, G. R., & Klever, H. D. (1991a). Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. American Journal of Psychiatry, 148, 1712-1716.
47. Satel, S. L., Southwick, S. M., & Gawin, & F. H. (1991b). Clinical features of cocaine induced paranoia. American Journal of Psychiatry, 149, 495-598.
48. Substance Abuse and Mental Health Administration. (1995). Preliminary estimates from the 1994 National Household Survey on Drug Abuse. Washington, DC: U.S. Government Printing Office.
49. Tilly, J., O'Brien, C. P., McLellan, A. T., Woody, G. E., Metzger, D. S., & Cornish, J. (1992). Naltrexone in the treatment of federal probationers. In L. Harris (Ed.), NIDA Research Monograph 119 (Publication no. ADM-92-188): 458. Washington, DC: U.S. Government Printing Office.
50. 2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology, 94, 213-215.
51. Volkow, N. D., Fowler, J. S., & Wolf, A. P. (1991). Use of PET to study cocaine in the human brain. In R. Rapaka &. M. Kuhar (Eds.), Emerging techniques for drug abuse research (NIDA Monograph Series, pp. 168-179). Rockville, MD: National Institutes of Health.
52. Volpicelli, J., Alterman, A., Hayashida, M., Muentz, L., & O'Brien, C. P. (1990). Naltrexone and the treatment of alcohol dependence. In L. D. Reid (Ed.), Opioids, bulimia and alcoholism (pp. 195-214). New York: Springer-Verlag.
53. Volpiceili, J. R., Alterman, A. I., Hayashida, M., & O'Brien, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880.
54. Walsh, D. C., Hingson, R. W., Merrigan, D. M., Levenson, S. M., Cupples, L. A., Heeren, T., Coffman, G. A., Becker, C. A., Barker, T. A., Hamilton, S. K., McGuire, T. G., & Kelly, C. E. (1991). A randomized trial of treatment options for alcohol-abusing workers. New England Journal of Medicine, 325, 775-782.
55. Weiss, S. R. B., Post, R. M., Szele, F., Woodward, R., & Nierenberg, J. (1989). Chronic carbamazepine inhibits the development of local anesthetic seizures kindled by cocaine and lidocaine. Brain Research, 497, 72-79.
56. Woody, G. E., O'Brien, C. P., McLellan, A. T., & Evans, B. D. (1982). Use of antidepressants along with methadone in maintenance patients. Annals of the New York Academy of Sciences, 398, 120-127.
57. Zacny, J. C. (1995). A review of the effects of opioids on psychomotor and cognitive functioning in humans. Experimental and Clinical Psychopharmacology, 3, 432-466.